Position in RARE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$30,729,282
+$19,509,175 QoQ
Shares Held
920,314
+71.8% QoQ
Ownership
0.933%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 311 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in RARE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. RARE ranks #54 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in RARE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,729,282 | 920,314 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $11,220,107 | 535,566 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $12,113,778 | 526,686 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $15,016,896 | 499,232 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $17,942,567 | 493,470 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $20,581,363 | 568,389 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $22,253,555 | 528,965 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $26,293,146 | 473,324 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $15,695,307 | 381,881 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $17,164,315 | 367,623 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $17,916,287 | 374,661 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $11,499,654 | 322,571 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $14,409,303 | 312,363 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $12,218,870 | 304,710 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $13,797,675 | 297,813 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $13,955,003 | 336,996 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $20,015,511 | 335,493 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $24,523,483 | 337,696 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $28,552,673 | 339,549 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $30,918,303 | 342,813 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $32,808,121 | 344,081 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $83,296,330 | 731,568 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $107,392,746 | 775,791 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $61,005,935 | 742,255 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $60,890,278 | 778,449 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $32,038,604 | 721,103 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||